Skip to main content
. 2014 Aug 29;9(8):e105268. doi: 10.1371/journal.pone.0105268

Table 6. Predictive factors of survival after the development of the first SRE.

VARIABLES MEDIAN TIME[MONTHS- (95% C.I.)] p VALUE(univariate) p VALUE(multivariate) HAZARDRATIO (HR)
Age 0.872
<70 Years 2.0 (0.63–3.37)
>70 Years 2.0 (0.34–3.66)
SEX 0.799
Male 1.0 (0.00–2.21)
Female 3.0 (1.67–4.32)
Aetiology 0.339
HBV-related 0.0 (0.00–0.00)
HCV-related 3.0 (1.51− (4.49)
Alcohol-related cirrhosis 2.0 (0.93–3.07)
Other 0.0 (0.00–0.00)
Grading 0.847
G1 3.0 (0.06–5.94)
G2 2.0 (0.00–5.96)
G3 1.0 (0.00–2.16)
Locoregional Treatment 0.000 0.030 0.575
No 0.0 (0.00–0.00)
Yes 3.0 (1.91–4.10)
Type of locoregional Treatment 0.330
Surgery 4.0 (2.90–5.10)
Interventional Radiology 2.0 (0.51–3.50)
Type of interventional Radiology 0.089
RFA 3.0 (1.21–4.79)
TACE 2.0 (2.32–5.80)
PEI 1.0 (0.00–10.70)
CHILD Score (at time of Bone Metastasis) 0.509
A 1.0 (0.00–3.49)
B 3.0 (2.26–3.74)
C 4.0 (2.06–5.95)
AFP (median value at diagnosis) 0.186
<43 ng\ml 3.0 (1.80–4.20)
>43 ng/ml 1.0 (0.70–3.10)
Visceral Metastasis 0.119
Yes 1.0 (0.00–1.94)
No 2.0 (1.06–2.95)
ECOG PS (at time of Bone Metastasis) 0.115
0 1.0 (0.00–3.34)
1 3.0 (1.65–4.35)
2 2.0 (0.00–4.31)
3 0.0 (0.00–0.00)
Bone Lesion Type 0.362
Osteolytic 2.0 (0.44–3.57)
Ostroblastic 2.0 (0.88–3.12)
Mixed 2.0 (0.00–4.11)
Bone metastasis - Spine 0.027 0.000 2.049
No 3.0 (1.30–4.70)
Yes 1.0 (0.00–2.00)
Bone Metastasis - Long Bones 0.191
No 1.0 (0.00–2.16)
Yes 4.0 (2.73–5.27)
Bone Metastasis - Hip 0.382
No 2.0 (0.84–3.16)
Yes 2.0 (0.00–4.19)
Bone Metastasis - Other 0.154
No 3.0 (2.19–3.81)
Yes 0.0 (0.00–0.00)
First SRE Type 0.024 0.239 0.935
Pathologica Fracture 4.0 (2.24–5.76)
Hypercalcemia 5.0 (0.00–10.13)
Spinal Cord Compression 2.0 (0.33–3.67)
Surgery to Bone 3.0 (0.00–7.80)
Radiation to Bone 5.0 (3.80–6.20)
Biphosphonate Treatment 0.001 0.727 0.931
No 0.0 (0.00–0.00)
Yes 4.0 (2.99–5.02)